GLP-1 Drug Market: How Are GLP-1 Drugs Expanding Beyond Diabetes...

ha aggiunto una foto Health

2026-04-06 11:53:58 -

GLP-1 Drug Market: How Are GLP-1 Drugs Expanding Beyond Diabetes and Obesity?

GLP-1 drug indication expansion — the investigation and regulatory development of GLP-1 receptor agonists for heart failure, kidney disease, NASH (metabolic liver disease), sleep apnea, addiction, Alzheimer's, and Parkinson's disease — represents the indication pipeline that will potentially expand the GLP-1 market far beyond metabolic disease, with the GLP-1 Drug Market reflecting...

0 Commenti 0 condivisioni 18 Views 0 Anteprima